Superior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Halbroth, Benedict R ^a   Heil, Alexander ^a   Distler, Eva ^a   Dass, Martin ^b   Wagner, Eva M ^a   Plachter, Bodo ^a   Probst, Hans Christian ^a   Strand, Dennis ^a   Hartwig, Udo F ^a   Karner, Anita ^c   Aichinger, Gerald ^c   Kistner, Otfried ^c   Landfester, Katharina ^b   Herr, Wolfgang ^a,d  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b MAX PLANCK INSTITUTE FOR POLYMER RESEARCH   (Germany)

^c BAXTER INNOVATIONS GMBH   (Austria)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; CYTOSOL; DENDRITIC CELL; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHARMACOLOGY; IN VITRO STUDY; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; MEMORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; CELL DIFFERENTIATION; CLASSIFICATION; CYTOLOGY; ENDOSOME; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLUENZA A VIRUS; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; ORTHOMYXOVIRIDAE; T LYMPHOCYTE SUBPOPULATION; ULTRASTRUCTURE; VIROLOGY; YOUNG ADULT;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; ENDOSOMES; HUMANS; IMMUNOLOGIC MEMORY; IN VITRO TECHNIQUES; INFLUENZA A VIRUS; INFLUENZA VACCINES; LYMPHOCYTE ACTIVATION; MIDDLE AGED; ORTHOMYXOVIRIDAE; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84904959154     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103392     Document Type: Article

References (44)

1. Webster RG, Govorkova EA (2006) H5N1 influenza - continuing evolution and spread. N Engl J Med 355: 2174-2177. (Pubitemid 44791158)
2. Neumann G, Kawaoka Y (2011) The first influenza pandemic of the new millennium. Influenza Other Respi Viruses 5: 157-166.
3. Herfst S, Schrauwen EJA, Linster M, Chutinimitkul S, de Wit E, et al. (2012) Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336: 1534-1541.
4. Doherty PC, Kelso A (2008) Toward a broadly protective influenza vaccine. J Clin Invest 118: 3273-3275.
5. Kistner O, Howard MK, Spruth M, Wodal W, Brühl P, et al. (2007) Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. Vaccine 25: 6028-6036. (Pubitemid 47077543)
6. Cox RJ, Brokstad KA, Ogra P (2004) Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59: 1-15. (Pubitemid 38186834)
7. Rimmelzwaan GF, Kreijtz JHCM, Bodewes R, Fouchier RAM, Osterhaus ADME (2009) Influenza virus CTL epitopes, remarkably conserved and remarkably variable. Vaccine 27: 6363-6365.
8. Yap KL, Ada GL, McKenzie IF (1978) Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273: 238-239. (Pubitemid 8331715)
9. Bender BS, Croghan T, Zhang L, Small PA (1992) Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175: 1143-1145.
10. Furuya Y, Chan J, Regner M, Lobigs M, Koskinen A, et al. (2010) Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses. J Virol 84: 4212-4221.
11. Bender A, Bui LK, Feldman MA, Larsson M, Bhardwaj N (1995) Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J Exp Med 182: 1663-1671.
12. Howard MK, Kistner O, Barrett PN (2008) Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines. Biol Chem 389: 569-577. (Pubitemid 351874194)
13. Barrett PN, Mundt W, Kistner O, Howard MK (2009) Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev Vaccines 8: 607-618.
14. European Medicines Agency (EMA) (2012) Vepacel - Influenza vaccine (whole virion, inactivated). Annex I - Summary of product characteristics. Available: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR---Product-Information/ human/002089/WC500124223.pdf. Accessed 4 August 2013.
15. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, et al. (1998) Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16: 960-968. (Pubitemid 28276008)
16. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15: 532-4, 536-7.
17. Jonuleit H, Kühn U, Müller G, Steinbrink K, Paragnik L, et al. (1997) Proinflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27: 3135-3142. (Pubitemid 28018007)
18. Kleemann P, Distler E, Wagner EM, Thomas S, Klobuch S, et al. (2012) Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation. Haematologica 97: 874-882.
19. Walther P, Ziegler A (2002) Freeze substitution of high-pressure frozen samples: the visibility of biological membranes is improved when the substitution medium contains water. J Microsc 208: 3-10. (Pubitemid 35365577)
20. Takeuchi O, Akira S (2009) Innate immunity to virus infection. Immunol Rev 227: 75-86.
21. Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7: 179-190.
22. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, et al. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529. (Pubitemid 38314424)
23. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531. (Pubitemid 38314425)
24. Jong MD de, Simmons CP, Thanh TT, Hien VM, Smith GJD, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207. (Pubitemid 44527358)
25. Geeraedts F, Goutagny N, Hornung V, Severa M, de Haan A, et al. (2008) Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog 4: e1000138.
26. Koyama S, Coban C, Aoshi T, Horii T, Akira S, et al. (2009) Innate immune control of nucleic acid-based vaccine immunogenicity. Expert Rev Vaccines 8: 1099-1107.
27. Pichlmair A, Schulz O, Tan CP, Näslund TI, Liljeström P, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001. (Pubitemid 44749946)
28. Kreijtz JHCM, Osterhaus ADME, Rimmelzwaan GF (2009) Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control. Hum Vaccin 5: 126-135.
29. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, et al. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A 96: 10403-10408. (Pubitemid 29422570)
30. Cerundolo V, Benham A, Braud V, Mukherjee S, Gould K, et al. (1997) The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur J Immunol 27: 336-341. (Pubitemid 27046096)
31. Budimir N, Meijerhof T, Wilschut J, Huckriede A, de Haan A (2010) The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes. Vaccine 28: 8280-8287.
32. Neefjes J, Jongsma MLM, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11: 823-836.
33. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245-252. (Pubitemid 28155090)
34. Jameson J, Cruz J, Terajima M, Ennis FA (1999) Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol 162: 7578-7583. (Pubitemid 29277740)
35. Lee LY, Ha DLA, Simmons C, de Jong MD, van Chau NV, et al. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118: 3478-3490.
36. Goy K, Bibra S von, Lewis J, Laurie K, Barr I, et al. (2008) Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza. Influenza Other Respi Viruses 2: 115-125.
37. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106: 20365-20370.
38. Boon ACM, de Mutsert G, van Baarle D, Smith DJ, Lapedes AS, et al. (2004) Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol 172: 2453-2460. (Pubitemid 38182395)
39. Kreijtz JHCM, de Mutsert G, van Baalen CA, Fouchier RAM, Osterhaus ADME, et al. (2008) Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82: 5161-5166. (Pubitemid 351705225)
40. Brown LE, Kelso A (2009) Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol Cell Biol 87: 300-308.
41. Bui H, Peters B, Assarsson E, Mbawuike I, Sette A (2007) Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci U S A 104: 246-251. (Pubitemid 46068017)
42. Ehrlich HJ, Müller M, Oh HML, Tambyah PA, Joukhadar C, et al. (2008) A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 358: 2573-2584. (Pubitemid 351831358)
43. Tambyah PA, Wilder-Smith A, Pavlova BG, Barrett PN, Oh HML, et al. (2012) Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine. Vaccine 30: 329-335.
44. Nicholson KG, Tyrrell DA, Harrison P, Potter CW, Jennings R, et al. (1979) Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand 7: 123-136. (Pubitemid 9149059)